Lantheus Holdings (LNTH) Net Cash Flow (2014 - 2026)
Lantheus Holdings (LNTH) reported Net Cash Flow of $139.5 million for Q1 2026, up 444.33% year-over-year from $25.6 million in Q1 2025, and up 730.66% quarter-over-quarter from -$22.1 million in Q4 2025.
Lantheus Holdings (LNTH) Net Cash Flow (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Net Cash Flow data on file, last reported at $139.5 million in Q1 2026.
- Net Cash Flow for Q1 2026 came in at $139.5 million, up 444.33% year-over-year; the trailing twelve-month figure through Mar 2026 was -$439.7 million (down 298.12% YoY), and the FY2025 annual result was -$553.6 million, down 376.53% from the prior year.
- Net Cash Flow improved to $139.5 million in Q1 2026 per LNTH's latest filing, from -$22.1 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $200.1 million in Q3 2023 and troughed at -$313.3 million in Q3 2025.
- A 5-year average of $23.6 million and a median of $47.5 million in 2024 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2022 and 2025: Net Cash Flow jumped 43981.96% in 2022, then plunged 713.54% in 2025.
- A 5-year view of Net Cash Flow shows it stood at $158.5 million in 2022, then plunged by 37.04% to $99.8 million in 2023, then plunged by 52.42% to $47.5 million in 2024, then plunged by 146.59% to -$22.1 million in 2025, then jumped by 730.66% to $139.5 million in 2026.
- Business Quant data shows LNTH's Net Cash Flow at $139.5 million in Q1 2026, -$22.1 million in Q4 2025, and -$313.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 202.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -526.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -112.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -768.22 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 139.49 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -3.97 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 32.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 139.49 Mn |
| Mar 31, 2026 | 139.49 Mn |
| Dec 31, 2025 | -22.12 Mn |
| Dec 31, 2025 | -22.12 Mn |
| Sep 30, 2025 | -313.34 Mn |
| Sep 30, 2025 | -313.34 Mn |
| Jun 30, 2025 | -243.78 Mn |
| Jun 30, 2025 | -243.78 Mn |
| Mar 31, 2025 | 25.63 Mn |
| Mar 31, 2025 | 25.63 Mn |
| Dec 31, 2024 | 47.47 Mn |
| Dec 31, 2024 | 47.47 Mn |
| Sep 30, 2024 | 109.13 Mn |
| Sep 30, 2024 | 109.13 Mn |
| Jun 30, 2024 | 39.73 Mn |
| Jun 30, 2024 | 39.73 Mn |
| Mar 31, 2024 | 3.86 Mn |
| Mar 31, 2024 | 3.86 Mn |
| Dec 31, 2023 | 99.77 Mn |
| Dec 31, 2023 | 99.77 Mn |